535 related articles for article (PubMed ID: 15882358)
1. The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME; Gouras G; Relkin NR; Szabo P
Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
[TBL] [Abstract][Full Text] [Related]
2. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
Solomon B
Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated immunotherapy for Alzheimer's disease.
Solomon B
Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
6. Immunology and immunotherapy of Alzheimer's disease.
Weiner HL; Frenkel D
Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431
[TBL] [Abstract][Full Text] [Related]
7. [Perspectives in immunotherapy of Alzheimer's disease].
Rossi G
Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
[TBL] [Abstract][Full Text] [Related]
8. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
Beckman M
Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
[No Abstract] [Full Text] [Related]
9. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
Schenk D
Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
[No Abstract] [Full Text] [Related]
10. Current progress in beta-amyloid immunotherapy.
Schenk D; Hagen M; Seubert P
Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
Arbel M; Solomon B
Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
[TBL] [Abstract][Full Text] [Related]
12. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
Foster JK; Verdile G; Bates KA; Martins RN
Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
[TBL] [Abstract][Full Text] [Related]
15. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
Solomon B
Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
[TBL] [Abstract][Full Text] [Related]
17. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.
DeMattos RB; Bales KR; Cummins DJ; Dodart JC; Paul SM; Holtzman DM
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8850-5. PubMed ID: 11438712
[TBL] [Abstract][Full Text] [Related]
18. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
Wang CY; Finstad CL; Walfield AM; Sia C; Sokoll KK; Chang TY; Fang XD; Hung CH; Hutter-Paier B; Windisch M
Vaccine; 2007 Apr; 25(16):3041-52. PubMed ID: 17287052
[TBL] [Abstract][Full Text] [Related]
19. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
[TBL] [Abstract][Full Text] [Related]
20. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
